InSitu Technologies Inc.

InSitu Technologies Inc. is a privately held medical device company specializing in intra-vascular stents and cardiovascular products for coronary and peripheral intervention. The company manufactures a portfolio of covered stents, drug-eluting stents, and drug-coated balloons designed for minimally invasive vascular intervention. Product lines include: Celosia™ Covered Stent for treatment of free coronary perforations in native vessels ≥2.25mm diameter; Silene™ Covered Stent for peripheral vascular applications; Siro™ Drug Eluting Stent utilizing sirolimus coating and patented Direct-Stent® design to reduce restenosis; Kauree™ Covered Stent (coming soon) for tracheobronchial strictures caused by malignant neoplasms; and AaRiss™ Drug Coated Balloon for coronary and peripheral use. The company reports 25+ years of operational history with distribution spanning over 40 countries across six continents, 219,470+ stents implanted, and 190,560+ PTCA balloon catheters deployed. InSitu emphasizes physician collaboration in product design and maintains in-house capabilities for design, development, manufacturing, and licensing. The company participates in major international cardiology conferences including EuroPCR. Regulatory status and specific FDA clearances are not detailed in available content.